Depressive DisordersAnxiety DisordersNeuroimaging & Brain MeasuresKetaminePlacebo

Ketamine's acute effects on negative brain states are mediated through distinct altered states of consciousness in humans

This placebo-controlled study (n=13) investigated the effects of ketamine (3.5-35mg/70kg) on altered states of consciousness (ASCs) and their neural mechanisms. It examined the impact of different doses of ketamine on emotional task-evoked brain activity and various components of dissociation and ASCs. The study found that ketamine-induced ASCs had differential effects on brain activity, with higher depersonalization relieving negative brain states, while dissociative amnesia exacerbated insula activity. These results may provide insights into how specific dissociative states predict the response to ketamine in individuals with depression.

Authors

  • Boris Heifets
  • Trisha Suppes
  • Xue Zhang

Published

Nature Communications
individual Study

Abstract

Ketamine commonly and rapidly induces dissociative and other altered states of consciousness (ASCs) in humans. However, the neural mechanisms that contribute to these experiences remain unknown. We used functional neuroimaging to engage key regions of the brain’s affective circuits during acute ketamine-induced ASCs within a randomized, multi-modal, placebo-controlled design examining placebo, 0.05 mg/kg ketamine, and 0.5 mg/kg ketamine in nonclinical adult participants (NCT03475277). Licensed clinicians monitored infusions for safety. Linear mixed effects models, analysis of variance, t-tests, and mediation models were used for statistical analyses. Our design enabled us to test our pre-specified primary and secondary endpoints, which were met: effects of ketamine across dose conditions on (1) emotional task-evoked brain activity, and (2) sub-components of dissociation and other ASCs. With this design, we also could disentangle which ketamine-induced affective brain states are dependent upon specific aspects of ASCs. Differently valenced ketamine-induced ASCs mediated opposing effects on right anterior insula activity. Participants experiencing relatively higher depersonalization induced by 0.5 mg/kg of ketamine showed relief from negative brain states (reduced task-evoked right anterior insula activity, 0.39 SD). In contrast, participants experiencing dissociative amnesia showed an exacerbation of insula activity (0.32 SD). These results in nonclinical participants may shed light on the mechanisms by which specific dissociative states predict response to ketamine in depressed individuals.

Available with Blossom Pro

Research Summary of 'Ketamine's acute effects on negative brain states are mediated through distinct altered states of consciousness in humans'

Introduction

Hack and colleagues situate this study within a growing literature showing that subanesthetic ketamine commonly produces dissociative and other altered states of consciousness (ASCs) while also producing rapid changes in affective neural circuits and, in clinical samples, fast antidepressant effects. Prior work demonstrates that ketamine engages nodes of a negative affect circuit—particularly the anterior insula, amygdala, and anterior cingulate cortex (ACC)—but it remains unclear whether acute changes in neural activity in these regions depend on specific subjective ASCs. The authors note that dissociative experiences are heterogeneous, spanning states that may relieve negative affect (for example depersonalization or blissful states) and states that may be aversive (for example amnesia, anxiety, impaired control), and argue that separating these subcomponents is important for understanding ketamine's mechanisms and therapeutic effects.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Pro members can view the original manuscript directly in the browser.

Study Details

References (20)

Papers cited by this study that are also in Blossom

Antidepressant effects of ketamine in depressed patients

Berman, R. M., Cappiello, A., Anand, A. et al. · Biological Psychiatry (2000)

Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review

Jones, J. L., Mateus, C. F., Malcolm, R. J. et al. · Frontiers in Psychiatry (2018)

Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders

Whittaker, E., Dadabayev, A. R., Joshi, S. A. et al. · Therapeutic Advances in Psychopharmacology (2021)

Structure-based discovery of nonhallucinogenic psychedelic analogs

Cao, D., Yu, J., Wang, H. et al. · Science (2022)

Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature

Ionescu, D. F., Felicione, J. M., Gosai, A. et al. · Harvard Review of Psychiatry (2018)

The anterior cingulate cortex as a key locus of ketamine’s antidepressant action

Alexander, L., Jelen, L. A., Mehta, M. A. et al. · Neuroscience and Biobehavioral Reviews (2021)

Replication of Ketamine’s Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial

Zarate, C. A., Brutsche, N. E., Ibrahim, L. et al. · Biological Psychiatry (2012)

757 cited
Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression

Lally, N., Nugent, A. C., Luckenbaugh, D. A. et al. · Translational Psychiatry (2014)

253 cited
Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression

Niciu, M. J., Shovestul, B. J., Jaso, B. A. et al. · Journal of Affective Disorders (2018)

A qualitative and quantitative account of patient’s experiences of ketamine and its antidepressant properties

Sumner, R. L., Chacko, E., Mcmillan, R. et al. · Journal of Psychopharmacology (2021)

51 cited
Show all 20 references
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression

Murrough, J. W., Perez, A. M., Pillemer, S. et al. · Biological Psychiatry (2012)

Do the dissociative side effects of ketamine mediate its antidepressant effects?

Luckenbaugh, D. A., Niciu, M. J., Ionescu, D. F. et al. · Journal of Affective Disorders (2014)

A retrospective analysis of ketamine intravenous therapy for depression in real-world care settings

Mcinnes, L. A., Qian, J. J., Gargeya, R. S. et al. · Journal of Affective Disorders (2022)

43 cited
Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects

Nugent, A. C., Ballard, E. D., Gould, T. D. et al. · Molecular Psychiatry (2018)

223 cited
Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: analysis of the Clinician Administered Dissociative State Scale

Van Schalkwyk, G. I., Wilkinson, S. T., Davidson, L. et al. · Journal of Affective Disorders (2018)

65 cited
Psychometric evaluation of the altered states of consciousness rating scale (OAV)

Studerus, E., Gamma, A., Vollenweider, F. X. · PLOS ONE (2010)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

Ketamine's acute effects on negative brain states... — Research Summary & Context | Blossom